HomeCompareSTSA vs PLD

STSA vs PLD: Dividend Comparison 2026

STSA yields 136.36% · PLD yields 3.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 STSA wins by $9.65M in total portfolio value
10 years
STSA
STSA
● Live price
136.36%
Share price
$1.10
Annual div
$1.50
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$15.56M
Annual income
$6,371,447.45
Full STSA calculator →
PLD
PLD
● Live price
3.10%
Share price
$132.18
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.91M
Annual income
$4,750,725.19
Full PLD calculator →

Portfolio growth — STSA vs PLD

📍 STSA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSTSAPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, STSA + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
STSA pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

STSA
Annual income on $10K today (after 15% tax)
$11,590.91/yr
After 10yr DRIP, annual income (after tax)
$5,415,730.33/yr
PLD
Annual income on $10K today (after 15% tax)
$263.66/yr
After 10yr DRIP, annual income (after tax)
$4,038,116.41/yr
At 15% tax rate, STSA beats the other by $1,377,613.92/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of STSA + PLD for your $10,000?

STSA: 50%PLD: 50%
100% PLD50/50100% STSA
Portfolio after 10yr
$10.74M
Annual income
$5,561,086.31/yr
Blended yield
51.80%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

STSA
Analyst Ratings
4
Buy
9
Hold
Consensus: Hold
Altman Z
-7.4
Piotroski
2/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+2.9% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

STSA buys
0
PLD buys
0
No recent congressional trades found for STSA or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSTSAPLD
Forward yield136.36%3.10%
Annual dividend / share$1.50$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$15.56M$5.91M
Annual income after 10y$6,371,447.45$4,750,725.19
Total dividends collected$14.30M$5.78M
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusHoldBuy

Year-by-year: STSA vs PLD ($10,000, DRIP)

YearSTSA PortfolioSTSA Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$24,336$13,636.36$11,241$540.96+$13.1KSTSA
2$57,055$31,014.91$13,019$991.13+$44.0KSTSA
3$129,004$67,955.30$15,801$1,870.97+$113.2KSTSA
4$281,633$143,598.62$20,609$3,701.21+$261.0KSTSA
5$594,333$292,985.93$29,919$7,867.97+$564.4KSTSA
6$1,213,779$577,842.64$50,631$18,617.74+$1.16MSTSA
7$2,401,642$1,102,898.48$105,528$51,352.20+$2.30MSTSA
8$4,609,241$2,039,484.49$287,364$174,449.42+$4.32MSTSA
9$8,590,007$3,658,118.87$1,081,760$774,280.77+$7.51MSTSA
10$15,562,755$6,371,447.45$5,908,209$4,750,725.19+$9.65MSTSA

STSA vs PLD: Complete Analysis 2026

STSAStock

Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in SUMMIT Phase 3 efficacy trials and can be self-administered with proprietary pre-filled, single-use, and nasal delivery device. Satsuma Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.

Full STSA Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this STSA vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

STSA vs SCHDSTSA vs JEPISTSA vs OSTSA vs KOSTSA vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.